Scoping review: Evidence for long-term follow-up and monitoring in shoulder and elbow arthroplasty.

Autor:	Morris DLJ; Nottingham University Hospitals NHS Trust, Nottingham, UK., Candal-Couto J; Orthopaedic Surgery, Wansbeck Hospital, Ashington, UK., Watts AC; Upper Limb Unit, Wrightington Wigan and Leigh NHS Foundation Trust, Wigan, UK., Rangan A; South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK., Tambe A; Royal Derby Hospital, Derby, UK.
Jazyk:	angličtina
Zdroj:	Shoulder & elbow [Shoulder Elbow] 2023 Dec; Vol. 15 (6), pp. 593-601. Date of Electronic Publication: 2023 Feb 09.
DOI:	10.1177/17585732231156403
Abstrakt:	Aims: Long-term follow-up and monitoring of asymptomatic shoulder and elbow arthroplasty remains contentious, with a wide spectrum of non-evidence-based mechanisms used. This scoping review aims to outline related evidence, thereby informing research requirements. Methods: Studies relevant to shoulder and elbow arthroplasty follow-up, surveillance and time-related failure were included. The review included randomised controlled trials, systematic reviews and economic studies indexed in MEDLINE, Embase, Cochrane CDSR and Cochrane CENTRAL since 1 January 2012. In addition, all registry studies, follow-up studies, cohort studies and case reports indexed in MEDLINE since 1 January 2020 were included. The screening was undertaken by two reviewers. Key characteristics of each study were described, alongside a narrative review. Results: Twenty-one articles were included. We were unable to identify evidence that long-term follow-up and monitoring of asymptomatic shoulder and elbow arthroplasty identifies failure or leads to a revision that is of reduced patient morbidity and cost. In addition, no evidence was apparent to inform whether patients will self-present with a failing implant. Several surveillance mechanisms were identified. Conclusion: This scoping review highlights the paucity of evidence related to long-term follow-up and monitoring of shoulder and elbow arthroplasty, and the need for high-quality data to inform the development of evidence-based care pathways. Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. (© The Author(s) 2023.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu